Tamtam Try Tamtam free
Concentra logo

Concentra account plan

Occupational health services and physical therapy

At a glance

Concentra is the largest US occupational health provider by locations, with FY2025 revenue of $2,163.4 million and about 13,000 colleagues and clinicians.

Concentra provides occupational health services in the United States: injury care for workers' compensation and employer services such as drug screens and physicals, through stand-alone centers, onsite clinics at employer worksites and Concentra Telemed. It serves about 200,000 employers, including 100% of the Fortune 100, and handled 13.5 million patient visits in 2025. FY2025 revenue was $2,163.4 million, up 13.9%, with net income of $172.8 million and Adjusted EBITDA of $431.9 million (20.0% margin). It has about 13,000 colleagues and affiliated physicians and clinicians and is completing its separation from Select Medical.

Business units

Strategic priorities

Organic visit and rate growth
The long-term algorithm is low single digit visit growth, about 3% rate growth, and low single digits from M&A and de novos.
De novo openings
7 to 9 de novos targeted in 2026, with 15 new centers expected in 2026 overall and low double digit de novo openings in 2027; payback typically comes in under three years.
Bolt-on acquisitions
Small deals of one to five centers, such as 4 centers acquired in Minnesota and the Reliant acquisition from MBI; no larger deals expected near term.
Onsite and new services
Advanced primary care onsite, workers' compensation behavioral health via telemedicine, and adjacent areas such as workplace safety and specialty care; the onsite clinic market is estimated at about $17 billion.
Deleveraging and capital returns
A 2.5x leverage target, debt paydown and a new $250 million buyback programme authorised on November 4, 2026.

Latest results

In Q3 2026 revenue was $622.1 million, up 8.6%, driven mainly by organic growth in visit volume and revenue per visit; net income was $67.8 million against $49.8 million and Adjusted EBITDA $140.2 million (22.5% margin). Employer services visits rose 5.8%, helped by hiring-related drug screens and physicals in transportation, logistics, manufacturing and construction. Nine-month revenue was $1,797.7 million (+10.7%). 2026 guidance was raised to revenue of $2.36-2.38 billion and Adjusted EBITDA of $505-510 million, with free cash flow guidance kept at $220-240 million.

Investments and deals

Nova Medical Centers
67 centers acquired in March 2025 for $265.0 million.
Pivot Onsite Innovations
Over 240 onsite clinics acquired in June 2025 for $54.4 million.
New centers in 2026
7 centers acquired and 5 de novos opened in the first nine months of 2026, with de novos in Kansas City, Boise and Daytona Beach.
Debt paydown and buybacks
A $50.0 million voluntary term loan prepayment in Q3 2026; 2.1 million shares repurchased for $60.6 million in nine months.

Challenges and risks

State fee schedules
State workers' compensation fee schedules and cost containment drive rates; Concentra has no centers in New York because of its low fee schedule.
Labour costs
Labour shortages and wage costs are stated risks; wage inflation is about 3%.
Indebtedness
A $942.9 million term loan and $650.0 million senior notes at year-end 2025; the leverage ratio was 2.90x at September 30, 2026 against a 2.5x target.
Separation from Select Medical
Standalone public-company and separation costs raised G&A to 9.8% of revenue in Q3 2026; the transition services agreement ends at the end of November.

What leadership says

“enters in this next chapter from a position of considerable strength”

Keith Newton, Executive Chairman · Q3 2026 earnings call, 2026-11-06

“favorable labor market conditions in many of the blue collar sectors we serve, and continued market share gains”

Matthew T. DiCanio, President and Chief Executive Officer · Q3 2026 earnings call, 2026-11-06

“specialized clinical approach and fully integrated medical model”

Keith Newton, Chief Executive Officer · Q4 2025 earnings call, 2026-02-27

Where a supplier can help

Clinic build-out and fit-out
The de novo programme and bolt-on acquisitions need real estate, construction, medical equipment and IT set-up partners.
Clinical staffing and workforce tools
Labour shortages and wage costs make staffing, scheduling and retention solutions relevant to the cost of services gains.
Standalone back-office systems
The end of the Select Medical transition services agreement creates needs for finance, HR and IT systems and services.
Sales and account management technology
Sales teams use new technology and AI to spot customers at risk of churn; CRM, analytics and AI vendors fit the organic growth priority.
Onsite and telehealth services
Advanced primary care and behavioral health via telemedicine call for telehealth platforms and clinical partners.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Concentra?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Concentra

What does Concentra do?

Concentra provides occupational health services in the United States, treating work injuries for workers' compensation and providing employer services such as drug screens and physicals through centers, onsite clinics and telemedicine.

What is Concentra's revenue?

FY2025 revenue was $2,163.4 million, up 13.9%. 2026 guidance is revenue of $2.36-2.38 billion.

How many employees does Concentra have?

About 13,000 colleagues and affiliated physicians and clinicians.

Who leads Concentra?

Since November 1, 2026, Matthew T. DiCanio is CEO, Tanner Newton CFO and Keith Newton executive chairman.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)